Sano Genetics wrote about how the shift from treating rare disease trials as fixed costs of one study to infrastructure across programs and years changes the financial aspect of rare disease development.

At Sano, our mission is to accelerate the world's transition to precision medicine. Sano combines genetic testing, recruitment, and long-term engagement in one platform, accelerating enrollment and simplifying operations for precision medicine teams driving breakthroughs for patients.

Founded 2016